Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579891 · ClinicalTrials.gov registry record
Tissue and Serum Collection From Colorectal Cancer Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 726
- Enrollment target
NCT00579891: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579891 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 726 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579891 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 726 participants
- Enrollment target
Study Summary
To establish a serum and tissue bank with specimens form patients with colorectal cancer, for subsequent immunological and biochemical analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 726 participants |
| Start Date | 1989-03-28 |
| Est. Completion | 2020-12-18 |
What the finished NCT00579891 record still lists
NCT00579891 is an observational study that tracks outcomes without assigning an intervention. The registered 726 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00579891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579891 about?
NCT00579891 is a clinical study titled "Tissue and Serum Collection From Colorectal Cancer Patients". To establish a serum and tissue bank with specimens form patients with colorectal cancer, for subsequent immunological and biochemical analysis.
What is the current status of trial NCT00579891?
This trial is currently completed. The enrollment target is 726 participants. The study started on 1989-03-28. Estimated completion is 2020-12-18.
Who is sponsoring clinical trial NCT00579891?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06731478 · 726 participants · Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- NCT05634967 · 725 participants
Kesimpta (Ofatumumab) Pregnancy Registry
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI